Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 24

1.

Lithium Therapy Associated With Renal and Upper and Lower Urinary Tract Tumors: Results From a Retrospective Single-Center Analysis.

Gahr M, Wezel F, Bolenz C, Connemann BJ, Schönfeldt-Lecuona C, Muche R, Fohrer C.

J Clin Psychopharmacol. 2019 Aug 14. doi: 10.1097/JCP.0000000000001098. [Epub ahead of print] No abstract available.

PMID:
31425462
2.

A systematic review of dimensions evaluating patient experience in chronic illness.

Forestier B, Anthoine E, Reguiai Z, Fohrer C, Blanchin M.

Health Qual Life Outcomes. 2019 Jan 21;17(1):19. doi: 10.1186/s12955-019-1084-2.

3.

Minimal residual disease negativity using deep sequencing is a major prognostic factor in multiple myeloma.

Perrot A, Lauwers-Cances V, Corre J, Robillard N, Hulin C, Chretien ML, Dejoie T, Maheo S, Stoppa AM, Pegourie B, Karlin L, Garderet L, Arnulf B, Doyen C, Meuleman N, Royer B, Eveillard JR, Benboubker L, Dib M, Decaux O, Jaccard A, Belhadj K, Brechignac S, Kolb B, Fohrer C, Mohty M, Macro M, Richardson PG, Carlton V, Moorhead M, Willis T, Faham M, Anderson KC, Harousseau JL, Leleu X, Facon T, Moreau P, Attal M, Avet-Loiseau H, Munshi N.

Blood. 2018 Dec 6;132(23):2456-2464. doi: 10.1182/blood-2018-06-858613. Epub 2018 Sep 24.

PMID:
30249784
4.

Characterization of efficacy and safety of pathogen inactivated and quarantine plasma in routine use for treatment of acquired immune thrombotic thrombocytopenic purpura.

Herbrecht R, Ojeda-Uribe M, Kientz D, Fohrer C, Bohbot A, Hinschberger O, Liu KL, Remy E, Ernst C, Lin JS, Corash L, Cazenave JP.

Vox Sang. 2018 May 21. doi: 10.1111/vox.12663. [Epub ahead of print]

PMID:
29786866
5.

Heavy + light chain analysis to assign myeloma response is analogous to the IMWG response criteria.

Fouquet G, Snell KI, Guidez S, Schraen S, Boyle E, Renaud L, Desmier D, Machet A, Moya N, Systchenko T, Gruchet C, Decaux O, Arnulf B, Fohrer C, Richez V, Kolb B, Macro M, Karlin L, Royer B, Pegourie B, Hebraud B, Caillot D, Perrot A, Moreau P, Facon T, Avet-Loiseau H, Dejoie T, Hulin C, Harding S, Leleu X.

Leuk Lymphoma. 2018 Mar;59(3):583-589. doi: 10.1080/10428194.2017.1339876. Epub 2017 Jul 12.

PMID:
28697637
6.

FDG PET to Diagnose Neurolymphomatosis in a Case of Triple-Hit B-Cell Lymphoma.

Bund C, Heimburger C, Trensz P, Fohrer C, Kremer S, Namer IJ.

Clin Nucl Med. 2017 Jun;42(6):458-460. doi: 10.1097/RLU.0000000000001608.

PMID:
28240665
7.

[Pomalidomide for multiple myeloma].

Fouquet G, Macro M, Decaux O, Fohrer C, Guidez S, Demarquette H, Le Grand C, Prodhomme C, Renaud L, Bories C, Herbaux C, Karlin L, Roussel M, Benboubker L, Hulin C, Arnulf B, Leleu X.

Rev Med Interne. 2015 Sep;36(9):613-8. doi: 10.1016/j.revmed.2015.04.007. Epub 2015 Aug 6. Review. French.

PMID:
26257103
8.

Deletion of the 1p32 region is a major independent prognostic factor in young patients with myeloma: the IFM experience on 1195 patients.

Hebraud B, Leleu X, Lauwers-Cances V, Roussel M, Caillot D, Marit G, Karlin L, Hulin C, Gentil C, Guilhot F, Garderet L, Lamy T, Brechignac S, Pegourie B, Jaubert J, Dib M, Stoppa AM, Sebban C, Fohrer C, Fontan J, Fruchart C, Macro M, Orsini-Piocelle F, Lepeu G, Sohn C, Corre J, Facon T, Moreau P, Attal M, Avet-Loiseau H.

Leukemia. 2014 Mar;28(3):675-9. doi: 10.1038/leu.2013.225. Epub 2013 Jul 29.

9.

Trastuzumab for treatment of refractory/relapsed HER2-positive adult B-ALL: results of a phase 2 GRAALL study.

Chevallier P, Robillard N, Charbonnier A, Raffoux E, Maury S, Carras S, Chabrot C, Fohrer C, Bernard M, Blade JS, Etienne A, Talmant P, Delaunay J, Guillaume T, Mohty M, Bene MC, Ifrah N, Dombret H.

Blood. 2012 Mar 15;119(11):2474-7. doi: 10.1182/blood-2011-11-390781. Epub 2012 Jan 20.

11.

Factors associated with overall and attributable mortality in invasive aspergillosis.

Nivoix Y, Velten M, Letscher-Bru V, Moghaddam A, Natarajan-Amé S, Fohrer C, Lioure B, Bilger K, Lutun P, Marcellin L, Launoy A, Freys G, Bergerat JP, Herbrecht R.

Clin Infect Dis. 2008 Nov 1;47(9):1176-84. doi: 10.1086/592255.

PMID:
18808352
12.

[Digital arteritis preceding the diagnosis of a malignant B cell lymphoma].

Kuhnert C, Groza M, Fohrer C, Weber JC.

Rev Med Interne. 2008 Aug;29(8):666-8. doi: 10.1016/j.revmed.2008.01.004. Epub 2008 Mar 5. French.

PMID:
18321612
13.

[18F]fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography for early evaluation of treatment efficacy in advanced non-Hodgkin lymphoma of uterine corpus: a case report.

Imperiale A, Blondet C, Fohrer C, Cimarelli S, Herbrecht R, Constantinesco A.

Clin Lymphoma Myeloma. 2007 May;7(6):421-4.

PMID:
17621408
14.

[Lipid formulations of amphotericin B in the management of invasive fungal infections].

Fohrer C, Nivoix Y, Moulin JC, Marçais A, Herbrecht R.

Therapie. 2006 May-Jun;61(3):235-42. Review. French.

PMID:
16989124
15.

Mycograb for the treatment of invasive candidiasis.

Herbrecht R, Fohrer C, Nivoix Y.

Clin Infect Dis. 2006 Oct 15;43(8):1083; author reply 1083-4. No abstract available.

PMID:
16983626
16.

Clinical antifungal efficacy trials in invasive aspergillosis: Consensus standards for trial design and room for improvement.

Nivoix Y, Fohrer C, Fornecker L, Herbrecht R.

Med Mycol. 2006 Sep 1;44(Supplement_1):S289-S294. doi: 10.1080/13693780600931986.

PMID:
30408917
17.

Long-term survival in post-transplant lymphoproliferative disorders with a dose-adjusted ACVBP regimen.

Fohrer C, Caillard S, Koumarianou A, Ellero B, Woehl-Jaeglé ML, Meyer C, Epailly E, Chenard MP, Lioure B, Natarajan-Ame S, Maloisel F, Lutun P, Kessler R, Moulin B, Bergerat JP, Wolf P, Herbrecht R.

Br J Haematol. 2006 Sep;134(6):602-12. Epub 2006 Aug 2.

PMID:
16889621
18.

Cytogenetic studies of a series of 43 consecutive secondary myelodysplastic syndromes/acute myeloid leukemias: conventional cytogenetics, FISH, and multiplex FISH.

Shali W, Hélias C, Fohrer C, Struski S, Gervais C, Falkenrodt A, Leymarie V, Lioure B, Raby P, Herbrecht R, Lessard M.

Cancer Genet Cytogenet. 2006 Jul 15;168(2):133-45.

PMID:
16843103
19.

Imatinib and methylprednisolone alternated with chemotherapy improve the outcome of elderly patients with Philadelphia-positive acute lymphoblastic leukemia: results of the GRAALL AFR09 study.

Delannoy A, Delabesse E, Lhéritier V, Castaigne S, Rigal-Huguet F, Raffoux E, Garban F, Legrand O, Bologna S, Dubruille V, Turlure P, Reman O, Delain M, Isnard F, Coso D, Raby P, Buzyn A, Caillères S, Darre S, Fohrer C, Sonet A, Bilhou-Nabera C, Béné MC, Dombret H, Berthaud P, Thomas X.

Leukemia. 2006 Sep;20(9):1526-32. Epub 2006 Jul 13.

PMID:
16838024
20.

Antifungal combination treatment: a future perspective.

Fohrer C, Fornecker L, Nivoix Y, Cornila C, Marinescu C, Herbrecht R.

Int J Antimicrob Agents. 2006 Jun;27 Suppl 1:25-30. Epub 2006 May 19. Review.

PMID:
16713193
21.

[A cytological, immunophenotypical and cytogenetical study of 136 consecutive cases of B-cell chronic lymphoid hemopathies].

Struski S, Leymarie V, Helias C, Falkenrodt A, Fohrer C, Audhuy B, Lioure B, Moskovtchenko P, Mazurier I, Galoisy AC, Gervais C, Mauvieux L, Herbrecht R, Bergerat JP, Lessard M.

Pathol Biol (Paris). 2007 Feb;55(1):59-72. Epub 2006 May 11. French.

PMID:
16690228
22.

Management of systemic fungal infections: alternatives to itraconazole.

Herbrecht R, Nivoix Y, Fohrer C, Natarajan-Amé S, Letscher-Bru V.

J Antimicrob Chemother. 2005 Sep;56 Suppl 1:i39-i48. Review.

PMID:
16120633
23.

Acremonium strictum pulmonary infection in a leukemic patient successfully treated with posaconazole after failure of amphotericin B.

Herbrecht R, Letscher-Bru V, Fohrer C, Campos F, Natarajan-Ame S, Zamfir A, Waller J.

Eur J Clin Microbiol Infect Dis. 2002 Nov;21(11):814-7. Epub 2002 Oct 31. Review.

PMID:
12461592
24.

[Post-therapy surveillance in non-Hodgkin's lymphomas].

Fohrer C, Oprea C, Herbrecht R.

Rev Prat. 2002 May 1;52(9):986-90. Review. French.

PMID:
12063766

Supplemental Content

Loading ...
Support Center